Lifesciences:
Generics: Active Pharmaceutical Ingredients & Intermediates
India offers quality APIs and its intermediates , Drug Fragments
and Research Building Blocks for regulated and non-regulated markets.
It has advantages of low cost of production, low R&D costs,
abundant scientific and technical manpower , strong intellectual
capital, excellent world-class national laboratories specialized
in development processes and cost effective technologies , an efficient
and cost effective source for procuring generic drugs, especially
the drugs going off patent in the next few years, an excellent centre
for clinical trials, USFDA/WHO complying manufacturing facilities.
|